OCHUKO DIAMREYAN: Open Payments
NPI 1134171408 · SAN BERNADINO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$828 in 25 payments from 5 companies in 2025. Trend: 2023 $806 · 2024 $543 · 2025 $828
Food & beverage: $828
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 12 | $496 |
| Axsome Therapeutics, Inc. | 6 | $160 |
| Janssen Pharmaceuticals, Inc | 5 | $122 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $25 |
Products named: ARISTADA, Auvelity, LYBALVI, INVEGA SUSTENNA, FANAPT, VRAYLAR.
Industry payments across CA — which companies pay providers there.
